Viewing StudyNCT06015126



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06015126
Status: RECRUITING
Last Update Posted: 2023-08-29
First Post: 2023-08-08

Brief Title: Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Sponsor: Yan Xue
Organization: Xian International Medical Center Hospital

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords: